FY2022 EPS Estimates for Cryoport, Inc. Cut by Analyst (NASDAQ:CYRX)

Cryoport, Inc. (NASDAQ:CYRXGet Rating) – Stock analysts at Jefferies Financial Group dropped their FY2022 earnings per share (EPS) estimates for Cryoport in a note issued to investors on Wednesday, November 16th. Jefferies Financial Group analyst B. Couillard now forecasts that the consumer goods maker will post earnings of ($0.91) per share for the year, down from their prior forecast of ($0.78). The consensus estimate for Cryoport’s current full-year earnings is ($0.88) per share. Jefferies Financial Group also issued estimates for Cryoport’s Q4 2022 earnings at ($0.22) EPS, Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings at ($0.06) EPS, Q3 2023 earnings at ($0.06) EPS, Q4 2023 earnings at ($0.05) EPS and FY2023 earnings at ($0.22) EPS.

A number of other brokerages also recently issued reports on CYRX. B. Riley reduced their price objective on Cryoport from $55.00 to $30.00 and set a “buy” rating for the company in a research note on Wednesday, November 16th. Needham & Company LLC decreased their price objective on Cryoport from $49.00 to $28.00 and set a “buy” rating on the stock in a report on Friday, November 4th. KeyCorp reduced their price target on Cryoport from $52.00 to $40.00 and set an “overweight” rating on the stock in a research report on Friday, November 4th. Finally, SVB Leerink cut their price objective on Cryoport from $45.00 to $28.00 and set an “outperform” rating on the stock in a research report on Friday, November 4th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, Cryoport has an average rating of “Buy” and a consensus target price of $42.17.

Cryoport Stock Performance

Shares of CYRX stock opened at $18.55 on Monday. Cryoport has a one year low of $15.79 and a one year high of $75.00. The company has a debt-to-equity ratio of 0.75, a current ratio of 14.96 and a quick ratio of 14.35. The business’s 50 day simple moving average is $24.94 and its 200 day simple moving average is $29.15. The stock has a market capitalization of $908.95 million, a PE ratio of -3.02 and a beta of 1.29.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. GW&K Investment Management LLC boosted its stake in shares of Cryoport by 3.7% in the first quarter. GW&K Investment Management LLC now owns 799,732 shares of the consumer goods maker’s stock worth $27,919,000 after acquiring an additional 28,415 shares during the period. DnB Asset Management AS bought a new position in Cryoport in the second quarter worth approximately $455,000. WCM Investment Management LLC grew its stake in Cryoport by 11.4% in the first quarter. WCM Investment Management LLC now owns 165,912 shares of the consumer goods maker’s stock worth $5,792,000 after purchasing an additional 16,938 shares in the last quarter. Moody Aldrich Partners LLC grew its stake in Cryoport by 42.8% in the first quarter. Moody Aldrich Partners LLC now owns 135,856 shares of the consumer goods maker’s stock worth $4,743,000 after purchasing an additional 40,734 shares in the last quarter. Finally, BerganKDV Wealth Management LLC grew its stake in Cryoport by 28.0% in the first quarter. BerganKDV Wealth Management LLC now owns 8,000 shares of the consumer goods maker’s stock worth $279,000 after purchasing an additional 1,750 shares in the last quarter. Hedge funds and other institutional investors own 90.33% of the company’s stock.

Cryoport Company Profile

(Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

Featured Articles

Earnings History and Estimates for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.